MONIKA G. KIRIPOLSKY, MD, FAAD
Board-Certified Dermatologist and Fellowship-Trained Cosmetic & Laser Surgeon
Permanent Medical Licenses in California and Illinois
EDUCATION & EMPLOYMENT
True Beauty: San Diego Skin and Laser, Carlsbad, CA
9/2010– Present
 Specializing in dermatology, dermatologic surgery, laser procedures, and cosmetic surgery
 Also performing varicose vein treatment/sclerotherapy, autologous fat transfer, and liposculpture/liposuction
GBK Cosmetic Laser Dermatology, San Diego, CA
8/2009 – 8/2010
 Completed 1-year fellowship in laser & cosmetic surgery; program accredited by the American Academy of
Cosmetic Surgery
 Served as the elected Director of Research for the practice, which entailed overseeing each step of the
approximately 35 clinical studies being conducted
North Coast Dermatology, Inc., Encinitas, CA
4/2009 – 7/2009
 Diagnosed/treated dermatologic diseases, performed surgical & cosmetic procedures and supervised physician
assistants
Dermatologist Medical Group of North County, Inc., La Jolla, CA
9/2008 – 2/2009
 Diagnosed and treated dermatologic conditions, read histopathology, and performed surgical and cosmetic
procedures
University of Illinois, Chicago, IL
7/2005 –7/2008
 Completed 3-year residency in the Department of Dermatology; became board-certified in dermatology in 2008
University of California – Irvine, Orange County, CA
2004 - 2005
 Completed an internship through the Internal Medicine Department
Vanderbilt University School of Medicine, Nashville, TN
1999 - 2004
 Earned an M.D. in 5/04
University of California, Los Angeles, Los Angeles, CA
1995 - 1999
 Bachelor of Science – Graduated from the UCLA Honors College
 Majored in Psychobiology with Specialization in Business and Economics
 Earned Magna Cum Laude distinction
HONORS & AWARDS
 Overall Fellowship Recipient 2003 – Funded dermatology rotation at Hospital San Pau, Barcelona, Spain - 6/2003
 Voting Member - Represented Vanderbilt Medical School at AMSA’s 51st Annual Convention - 3/2001
PUBLICATIONS
Kiripolsky MG, Peterson JD, Goldman MP. “Safety and efficacy of administering abobotulinumtoxinA through a
single injection point when treating lateral periocular rhytides.” J Cosmetic Dermatology [accepted for publication
7/2011].
Kiripolsky MG, Peterson JD, Goldman MP. “A two-phase, retrospective analysis evaluating efficacy and patient
satisfaction with AbobotulinumtoxinA when used to treat dynamic facial rhytides.” Dermatologic Surgery
[accepted for publication 4/2011].
Peterson JD, Palm M, Kiripolsky MG, Goldman MP. “Evaluation of the impact of fractional laser with
radiofrequency and a fractionated radiofrequency on the improvement of acne scars.” Dermatologic Surgery.
[accepted for publication 12/2010].
Peterson JD, Kiripolsky MG, Goldman MP. “MRSA superinfection delaying the diagnosis of atypical mycobacteria
infection: Report of a case.” J Cosmetic Dermatology [accepted for publication 11/2010].
1
Kiripolsky MG. “More on ethanolamine oleate as a vascular sclerosant.” Dermatologic Surgery. 36(7): 1153-4,
2010.
Kiripolsky MG. “More on hypertrichosis after sclerotherapy.” Dermatologic Surgery. 36: 1066-7, 2010.
Kiripolsky MG, Goldman MP; Editors: Goldman MP, Bergan JJ, and Geux JJ. 2010. Chapter 4: Pathophysiology of
Telangiectasias. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 5th Ed. Mosby Elsevier,
Philadelphia.
Kiripolsky MG, Goldman MP; Editors: Goldman MP, Bergan JJ, and Geux JJ. 2010. Chapter 8: Complications of
Sclerotherapy. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 5th Ed. Mosby Elsevier,
Philadelphia.
Kiripolsky MG, Goldman MP; Editors: Goldman MP, Bergan JJ, and Geux JJ. 2010. Chapter 13: Treatment of Leg
Telangiectasias with Laser and High-Intensity Pulsed Light. Sclerotherapy: Treatment of Varicose and
Telangiectatic Leg Veins. 5th Ed. Mosby Elsevier, Philadelphia.
Kiripolsky MG, Goldman MP; Editors: Goldman MP, Bergan JJ, and Geux JJ. 2010. Chapter 15: Setting up a
Sclerotherapy Practice. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 5th Ed. Mosby Elsevier,
Philadelphia.
Kiripolsky MG, Peterson JD, Goldman MP. “Retrospective analysis to assess efficacy and patient satisfaction of
Dysport compared to Botox in the treatment of dynamic rhytides.” (abstract and live presentation) Cosmetic
Surgery Forum 12/2009.
Hernandez C, Kiripolsky MG. “Persistent lower extremity ulcers after a pedicure.” Journal of General Internal
Medicine. (in press: MS# 6232).
Hernandez C, Worobec S, Gaitonde S, Kiripolsky MG, Aquino, K. "Progression of undiagnosed cutaneous T-cell
lymphoma during efalizumab therapy." Archives of Dermatology. 145(1): 92-3, 2009.
Kiripolsky MG, Peterson JD, Cohen JL, Gold MH, Goldman MP. “Benefits of using a hydroquinone/tretinoin skin
care system in patients undergoing intense pulse light therapy for photorejuvenation of the decolletage: a
randomized-controlled study.” American Society for Laser Medicine and Surgery Annual Meeting – accepted
12/2009 as an abstract and ePoster presentation.
Peterson JD, Palm MD, Kiripolsky MG, Goldman MP. “Evaluation of the impact of fractional laser (Matrix IR) and
fractionated radiofrequency (Matrix RF) on the improvement of acne scars.” American Society for Laser Medicine
and Surgery Annual Meeting - accepted abstract 12/2009 for an ePoster presentation.
Kiripolsky MG, Zic JA, Nelson RA. “Basal cell carcinoma treated with topical bexarotene 1% gel: an open label
controlled study.” Journal of the American Academy of Dermatology. 50(3): 122, 2004.
Lichon VC, Kiripolsky MG, Hill CH. “Long-term dapsone use and the development of Non-Hodgkin’s Lymphoma
in two patients with Hansen’s Disease: Coincidence or valid link?” Archives of Dermatology. (submitted).
Sams, HH, Kiripolsky MG, Bhat, LS, Stricklin GP. “Porphyria cutanea tarda, hepatitis C, and hemochromatosis: A
case report and review of the literature.” Cutis. 73(3): 188-90, 2004.
Zic JA, Kiripolsky MG, Hamilton K, Greer JP. 2004. Chapter 94: Cutaneous T-Cell Lymphoma: Mycosis Fungoides
and Sezary Syndrome. Wintrobe’s Clinical Hematology. 11th Ed.. Lippincott Williams & Wilkins, Philadelphia:
2485-520.
Sams HH, Kiripolsky MG, Boyd AS, King LE Jr. “Crohn’s disease of the penis masquerading as pyoderma
gangrenosum; a case report and review of the literature.” Cutis. 72(6): 432-7, 2003.
PRESENTATIONS/LECTURES
Kiripolsky MG. “Topical application of the secretion of Cryptomphalus Aspersa for the reduction in signs of facial
photoaging.” International Pharmaceutica Cantabria – Annual Meeting, 6/2011 [lecture/presentation; Santander,
Spain].
2
Kiripolsky MG. “The Role of Growth Factors in Skin Care.” The Aesthetics Show – Annual Meeting, 6/2011
[lecture/presentation; Las Vegas, NV].
Kiripolsky MG. “Peri-Procedure Modalities.” Society of Dermatology Skin Care Specialists – 9th Annual Scientific
Meeting, 2/2011 [lecture/presentation; New Orleans, LA].
Kiripolsky MG, Peterson JD, Goldman MP. “A two-phase, retrospective analysis of patient satisfaction with
abobotulinumtoxinA in the treatment of dynamic rhytides.” American Academy of Cosmetic Surgery – 27th
Annual Scientific Meeting, 1/2011 [presentation and abstract publication; Scottsdale, AZ].
Kiripolsky MG, Goldman MP, Detwiler S. “A comparison of endovenous laser delivery mode and wavelength on
varicose veins.” American College of Phlebology – 24th Annual Congress Meeting, 11/2010 [presentation and
abstract publication; Orlando, FL].
Kiripolsky MG, Peterson JD, Goldman MP. “A two-phase retrospective analysis evaluating efficacy and patient
satisfaction with Abobotulinumtoxin A when used to treat dynamic rhytides.” American Society for Dermatologic
Surgery/American Society of Cosmetic Dermatology & Aesthetic Surgery Annual Meeting, 10/2010. [presentation
and abstract publication; Scottsdale, AZ].
Kiripolsky MG, Krunic AL.“Metastatic Crohn’s-like colitis in a patient with Hermansky-Pudlak Syndrome”
[Presented at 65th Annual American Academy of Dermatology Convention 2/2007; Washington, DC].
Kiripolsky MG, Zic J, Nelson, R. “Nodular basal cell carcinoma treated with topical bexarotene 1% gel: An open
label controlled study.” [Presented at 62nd Annual American Academy of Dermatology Convention 2/2004; New
Orleans, LA].
Kiripolsky MG, Zic J. “Laboratory and clinical variables associated with response and survival in 50 patients with
refractory CTCL treated with photopheresis.” [Presented at 61st Annual American Academy of Dermatology
Convention 2/2003; San Francisco, CA].
GRAND ROUNDS
Kiripolsky MG. “Autoantibodies in Autoimmune Connective Tissue Disorders.” University of Illinois, Chicago
Medical Center 10/2007.
Kiripolsky MG. “Diseases of the Nail Unit.” University of Illinois, Chicago Medical Center 5/2007.
Kiripolsky MG. “CD30+ Lymphoproliferative Disorders: Update on Recent Research.” University of Illinois,
Chicago Medical Center 6/2006.
Kiripolsky MG. “CD30+ Lymphoproliferative Disorders: Lymphomatoid Papulosis and Primary Cutaneous
Anaplastic Large Cell Lymphoma.” Vanderbilt University Medical Center 5/2003.
ACTIVITIES
Contributing Editor
Journal of Dermatologic Surgery & Journal of Cosmetic Dermatology
2009 - 2010
 Review, suggest revisions for, and publish commentaries on manuscripts submitted for publication
consideration.
Instructor, Mastery of Lasers Course
American Society of Dermatologic Surgery; La Jolla, CA
2009
 Instructed attendees via a live demonstration with question and answer session on the eMatrix (infrared +
radiofrequency) laser
Volunteer for Skin Cancer Screening Day
American Academy of Dermatology, La Jolla, CA
2008 - 2009
 Performed full-body skin exams on members of the community and made recommendations regarding
biopsy of skin lesions suspicious for skin cancer
Voting Member, Resident Selection Committee
3
UIC, Department of Dermatology, Chicago, IL
2005 - 2006
 Selected as one of three dermatology residents to join faculty to screen applications and select candidates
for interviews
Chairman of Medical Center’s “Cadaver Ball”
Vanderbilt University, Nashville, TN
 Organized publicity, planning, and entertainment for this annual 800+ person gala
2004
Visiting Student Extern
Hospital San Pau – Servicio de Dermatologia, Barcelona, Spain
2003
 Participated in general, pediatric and cutaneous lymphoma clinics, and in inpatient dermatology consults
(in Spanish)
 Attended “XXXI Congreso Nacional de Dermatologia y Venereologia” in Bilbao, Spain
Sub-Investigator and Co-Author, Medical Scholars Program
VUMC, Division of Dermatology, Nashville, TN
2002 - 2003
 Served as sub-investigator of Phase 2 study using bexarotine 1% gel for treatment of basal cell carcinoma
 Co-authored Wintrobe's Textbook of Hematology chapter: “Cutaneous T-cell Lymphoma: Mycosis
Fungoides and Sézary Syndrome”
 Formulated Vanderbilt ALCL patient database and evaluated trends in disease diagnosis, prognosis, and
treatment
Dermatology Interest Group Leader, Student Advisory Committee
Vanderbilt University, Nashville, TN
2002 - 2003
 Designed sessions led by dermatology attendings and residents to encourage medical students interested
in dermatology
 Designed a website for the organization
(www.mc.vanderbilt.edu/medschool/derminterest/DIGWebSite.html)
 Promoted mentoring relationships between dermatology faculty and students
Admission Interview Student Representative
2002 - 2003
 Presented daily interactive sessions to interviewing applicants on curriculum, student life and jointdegree programs
 Coordinated presentations with faculty representative to focus on the strengths of Vanderbilt's medical
training program
Contributing Author, The Reporter (Vanderbilt Medical Center’s Newspaper)
2002 - 2004
 Composed weekly articles highlighting accomplishments of Vanderbilt Medical Center faculty and
students
Chairman of Social Events, Committee of Class Officers
2000 – 2003
 Planned inter/intra-class events to ensure extracurricular interests of medical students were supported by
administration
 Met regularly with Deans, Chancellor and fellow officers to integrate social and philanthropic events into
the curriculum
Chief Editor, The Paddle and The Oar
2000 - 2002
 Organized guide to Nashville and to 1st & 2nd year courses for incoming medical students
 Contributed to guide of clinical rotation requirements for rising 3rd year medical students
Chairman, “Second Look Weekend” (1st Annual)
2001
 Planned and implemented a 2-day informative and social event for recruitment of the top 75 medical
school candidates
Course Leader, Problem Solving Elective
2000 - 2001
 Led problem-based learning course for fellow medical students through presentation of clinical cases
with associated labs, histopathology, gross organ specimens, and imaging studies
Acting Student Member, Medical School Admissions Committee
4
2000 - 2001
 Selected by faculty and students to screen (approx 8 h/wk) and present all applicants at weekly
committee meetings
 Voted in all committee deliberations, reflecting the collective opinion of VMS’s student body
Chairman & Editor, Co-op Note-taking Service
 Led classmates in collective documentation of all 1st & 2nd year med student lectures
1999 - 2000
Participant, Introduction to Biomedical Research (Dermatology)
2000
Veterans Affairs Hospital, Nashville, TN
 Entered and analyzed data on the use of extracorporeal photopheresis to treat cutaneous T-cell lymphoma
(Dr. J. Zic)
 Created Excel spreadsheet programs to chart data; presented graphical findings to peers
RESEARCH STUDIES (in addition to those mentioned elsewhere above)
A Phase 3, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety of Repeat Administrations of
Reloxin® in the Treatment of Glabellar Lines
A Phase III, Multi-Center, Long-Term, Repeat-Treatment, Open-Label, Single-Arm Trial to Demonstrate the Safety
of Repeat Treatment with PurTox® for the Treatment of Glabellar Rhytides
A Side-by-Side Two-Hand Comparison Pilot Study of Fat Transplantation Harvested via Traditional Syringe
Aspiration versus Water Jet Aspiration
A Multi-center, Randomized, Double-Masked, Placebo-Controlled, Dose-Ranging Study of the Safety and Efficacy
of Subcutaneous Injections of a Novel β2-Adrenergic Receptor Agonist Compared with Placebo for the Reduction
of Abdominal Subcutaneous Adiposity
Treatment of Cellulite and Circumferential Fat Reduction with a 15 Watt Device Combining 650nm and 915nm Laser
Emission with Vacuum and Mechanical Massage to Diminish the Appearance of Thigh Cellulite
Evaluation of the Efficacy of Sequential Treatments with a 15 Watt Device Combining 650nm and 915nm Laser
Emission with Vacuum and Mechanical Massage in Pre- and Post-Lipoplasty Procedures
A Side-by-Side Comparison of the VelaShapeII and a Cold Laser Device for the Reduction of Thigh, Hip, and Waist
Circumference
A Split-Face Study to Evaluate the Efficacy and Tolerability of Combination Therapy with Azaleic Acid Gel and
Intense Pulse Light Therapy in the Treatment of Mild to Moderate Rosacea
A Single-Center, Randomized, Split-Face Study to Compare the Efficacy of Photodynamic Therapy with Metvixia
Using Blue versus Red Light Sources for Treatment of Facial Acne
A Split-Face Study Investigating A Novel Topical Photosensitizing Preparation Combined with Multiple Laser and
Light Sources for Photorejuvination
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of a Topical
Glutathione Patch For the Treatment of Moderate Acne Vulgaris
Treatment of Reticular and Telangiectatic Leg Veins: Double-Blind, Prospective Comparative Trial Between
Polidocanol and Hypertonic Saline
A Clinical Study Evaluating Efficacy and Patient Satisfaction with Use of a Topical Regimen Containing
Hydroquinone, Tretinoin, and Salicylic Acid compared to a Topical Placebo Regimen in Individuals Undergoing
Botulinum Toxin Injections as well as Injectable Hyaluronic Acid Filler to the Nasolabial Folds
A Phase III, Randomized, Side-by-Side Comparative Study of the 1064-nm Nd:YAG Laser to the 1320-nm Nd:YAG
Laser for the Treatment of Onychomycosis
A Phase IV, Randomized, Split-Face Study Comparing the Order of Administration of the Lumenis UltraPulse Active
FX and Deep Fx CO2 Laser for the Treatment of Rhytides, Photo-Damage, and Scarring
A Split-Face Study Investigating Acne Scar Reduction with a Fractionated Radiofrequency Device Versus a
Fractionated, Multiplex 1320nm and 1440nm Nd:YAG Laser
A Study Evaluating the Efficacy of an Integrated Vacuum-Assisted Diode Device For Laser Hair Reduction in Skin
Types IV-VI
Micro-Pulsed 1064-nm Nd:YAG Laser versus Long-Pulsed 1064-nm Nd:YAG Laser Treatment for Hair Reduction,
Pain Assessment, and Time Efficiency in Patients with Axillary Hypertrichosis
5
A Randomized, Side-by-Side, Placebo-Controlled Study Comparing Varying Settings of a Fractionated CO2 Laser in
the Treatment of Striae
Investigation of a Novel Post-Laser Resurfacing Skin Care Regimen Consisting of Both Ointment and Cream
Formulations
A Clinical Study Evaluating the Added Benefit, Safety, and Patient Satisfaction of Injectable Poly-l-lactic acid,
Sculptra, Combined with Intense Pulsed Light for Chest Rejuvenation
SOCIETIES, ASSOCIATIONS, AND FOREIGN LANGUAGE
 Member of: American Academy of Dermatology; American Medical Association, San Diego County Medical
Society, American Society for Laser Medicine and Surgery; American Society of Dermatologic Surgery; American
Academy of Cosmetic Surgery; American College of Phlebology, and Women’s Dermatologic Society
 Fluent in English and conversational Spanish
6